- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Vector Science and Therapeutics Corp: Vector Science grants options to directors | 1 | Stockwatch | ||
| Di | Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy | 1 | CNW | ||
| 13.05. | Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing | 3 | CNW | ||
| 12.05. | Vector Science and Therapeutics Corp: Vector enters manufacturing deal with MPP Group | 3 | Stockwatch | ||
| 11.05. | Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC | 1 | CNW | ||
| VECTOR SCIENCE AND THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 07.05. | Vector Science and Therapeutics Corp: Vector Science appoints Dobranowski, Kelly to board | 4 | Stockwatch | ||
| 06.05. | Vector Science & Therapeutics Expands Board of Directors with Appointment of Dr. Alexander Dobranowski and Scott Kelly | 3 | CNW | ||
| 01.05. | Vector Science and Therapeutics Corp: Vector applies for provisional patent | 1 | Stockwatch | ||
| 01.05. | Vector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery | 118 | PR Newswire | Platform Integrates Three Research Modalities Targeting the Electrical Properties of Tumor Biology in Pancreatic Cancer
MEQUON, Wis., May 1, 2026 /PRNewswire/ --... ► Artikel lesen | |
| 01.05. | Vector Science and Therapeutics Corp: Vector Science appoints Thompson as chairman | 1 | Stockwatch | ||
| 30.04. | Vector Science & Therapeutics: Ex-US-Gesundheitsminister Tommy Thompson wird Aufsichtsratsvorsitzender | 1 | Investing.com Deutsch | ||
| 30.04. | Tommy Thompson joins Vector Science as board chairman | 3 | Investing.com | ||
| 30.04. | Vector Science & Therapeutics Announces Tommy Thompson as Chairman of the Board | 1 | CNW | ||
| 25.04. | Vector Science and Therapeutics Corp: Vector Science 23,105,000-share private placement | 2 | Stockwatch | ||
| 25.04. | Opensesame Acquisition Corp: Opensesame Acquisition name change to Vector Science | 1 | Stockwatch | ||
| 25.04. | Vector Science and Therapeutics Corp: Vector Science to resume at April 28 open | 1 | Stockwatch | ||
| 24.04. | Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.): Vector Science and Therapeutics Announces Listing on the TSX Venture Exchange | 524 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 36,670 | +1,97 % | Während Merck, Amgen, Novo Nordisk und Fresenius Milliarden bewegen, wächst die Fantasie im Zelltherapie-Sektor | ||
| BRIGHTSPRING HEALTH SERVICES | 57,79 | -2,61 % | BrightSpring stockholders price 15M share offering at $58.75 | ||
| SIEMENS HEALTHINEERS | 34,650 | +3,43 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | +4,78 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen | |
| VERU | 4,310 | +91,56 % | VERU INC. - 8-K, Current Report | ||
| BILLIONTOONE | 105,37 | +7,13 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 14,920 | +9,38 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| GENEDX | 55,74 | +4,91 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| CARL ZEISS MEDITEC | 26,640 | +1,52 % | EQS-DD: Carl Zeiss Meditec AG: Peter Kameritsch, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.05.2026 / 14:57... ► Artikel lesen | |
| UNITEDHEALTH | 341,00 | +4,92 % | Aktien New York Ausblick: Techwerte unter Druck nach KI-Ausblick von Broadcom | NEW YORK (dpa-AFX) - Ein enttäuschender Ausblick des Chipkonzerns Broadcom dürfte am Donnerstag für Moll-Stimmung an der Technologiebörse Nasdaq sorgen. Der Broker IG taxierte den viel beachteten Branchenindex... ► Artikel lesen | |
| HEARTFLOW | 28,970 | +0,42 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| GERRESHEIMER | 25,900 | -1,52 % | Gerresheimer: APAS ermittelt - droht der nächste Skandal? | Gerresheimer steht wegen fehlerhafter Bilanzierungen zunehmend unter Druck, nachdem die APAS ein Verfahren gegen KPMG eingeleitet und die BaFin weitere mögliche Bilanzierungsfehler identifiziert hat.... ► Artikel lesen | |
| PROGYNY | 25,870 | +2,99 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| ALPHA TAU MEDICAL | 10,390 | +16,35 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| BUTTERFLY NETWORK | 5,105 | +11,46 % | Butterfly Network adds former B. Braun CEO to board |
Das Unternehmen VECTOR SCIENCE AND THERAPEUTICS CORP kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VECTOR SCIENCE AND THERAPEUTICS CORP finden Sie auf Wallstreet Online.